Dachaigh › Galar Alzheimer › New Jersey
Sgrùdaidhean clionaigeach Galar Alzheimer ann an New Jersey
Tha 25 sgrùdaidhean airson Galar Alzheimer a’ lorg phàirtichean aig làraichean ann an New Jersey.
Bailtean ann an New Jersey
Teacsa sgrùdaidh oifigeil (Beurla)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, West Long Branch
A’ fastadhÌre 2
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Bio Behavioral Health, Toms River
A’ fastadhÌre 2
Aoisean 55 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1664, Princeton
A’ fastadhÌre 3
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06937229A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- The Cognitive and Research Center of New Jersey - Springfield- Site Number : 8400005, Springfield
A’ fastadhÌre 2
Aoisean 55 gu 85 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07688213A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Advanced Memory Research Institute - CenExel - PPDS, Toms River
A’ fastadhÌre 3
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- CenExel Research - Toms River, Toms River
A’ fastadhÌre 2
Aoisean 55 gu 80 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- The Cognitive and Research Center of New Jersey, Ridgewood
- The Cognitive and Research Center of New Jersey, Springfield
A’ fastadhÌre 3
Aoisean 50 gu 90 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT07177352Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons
- Kessler Foundation, East Hanover
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT05048966A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- The Cognitive and Research Center of New Jersey, Springfield
- Advanced Clinical Institute, West Long Branch
A’ fastadhÌre 3
Aoisean 60 gu 85 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT06976203Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
- Hackensack Medical Center, Hackensack
A’ fastadh
Aoisean 50 gu 100 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT05295615A Postmarketing Study of Lecanemab for the Treatment of Participants With Alzheimer's Disease
- Eisai Trial Site #1, Nutley
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07821658A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Global Medical Institutes LLC; Princeton Medical Institute, Princeton
A’ fastadhÌre 3
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07011732A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Local Institution - 2650, Toms River
A’ fastadhÌre 3
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07011745Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0059, Livingston
- Local Institution - 0081, Toms River
A’ fastadhÌre 2
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- The Cognitive and Research Center of New Jersey - Ridgewood ( Site 1064), Ridgewood
- The Cognitive and Research Center of NJ ( Site 1057), Springfield
- CenExel- AMRI ( Site 1018), Toms River
A’ fastadhÌre 2
Aoisean 50 gu 85 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT07033494A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- CenExel AMRI, Toms River
A’ fastadhÌre 1
Aoisean 50 gu 85 · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT06297590A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Advanced Memory Research Institute of New Jersey, Toms River
A’ fastadhÌre 3
Aoisean 60 gu 85 · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Rutgers-Robert Wood Johnson Medical School, New Brunswick
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT06563895A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- The Cognitive and Research Center of New Jersey, Springfield
A’ fastadhÌre 3
Aoisean 55 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07602582A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- CenExel-HRI, Marlton
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 45 gu 85 · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT06657768A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease
- Eisai Trial Site #1, Nutley
A’ fastadhSgrùdadh amharc
Aoisean 19 agus nas sine · Gach gnè · Air ùrachadh 21 Gibl 2026 · NCT06810960Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
- Nuclear Imaging Institute, Englewood
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT07012993Exercise to Improve Brain Health in Older African Americans
- Rutgers, The State University of New Jersey - Newark campus, Newark
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 20 Gearr 2026 · NCT05597124ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults
- Rutgers - Institute for Health, New Brunswick
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 6 Gearr 2026 · NCT07392723Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Toms River
A’ fastadhÌre 2
Aoisean 50 gu 85 · Gach gnè · Air ùrachadh 2 Gearr 2026 · NCT07105709Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.